Sep. 27, 2023 — Lung fibrosis is a debilitating disease affecting nearly 250,000 people in the U.S. alone with 50,000 new cases reported each year. There is currently no cure and limited ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

More than 4,000 doses of PRM-151 have been administered to more than 250 patients over 6 years, and Promedior has just completed phase 2 trials in patients with idiopathic pulmonary fibrosis (IPF ...

VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers of disease in adults with pulmonary fibrosis ...

known as pulmonary fibrosis. The condition is irreversible and symptoms can include severe shortness of breath, coughing and fatigue. NHS England said it was opening specialist rehabilitation centres.

chronic obstructive pulmonary disease, cystic fibrosis, asthma, interstitial lung disease, bronchiectasis, benign and malignant neoplasms, and lung transplantation. The Lung Institute has developed a ...

22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

This can include many kinds of lung conditions, such as asthma, bronchitis, chronic obstructive pulmonary disease, pneumonia, cystic fibrosis, and others. University of Utah Health Pulmonary Services ...

The study of long COVID remains in its infancy, with no FDA-approved treatment available, but the pandemic may be spawning new research into other medical areas, says the head of Northwestern's ...

If you have a nagging cough, feel bubbling or wheezing in your chest, and can’t catch your breath, you may have some form of a lung infection, also known as pneumonia. This WebMD slideshow tells ...